Financhill
Back

Biogen, Inc. Stock Predictions

Biogen, Inc. Stock Forecast

  • Over the next 52 weeks, Biogen, Inc. has on average historically risen by 35.3% based on the past 34 years of stock performance.
  • Biogen, Inc. has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%
  • Is Biogen, Inc. Stock Undervalued?
    The current Biogen, Inc. [BIIB] share price is $180.75. The Score for BIIB is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Biogen, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Biogen, Inc. has on average historically risen by 35.3% based on the past 34 years of stock performance.

Biogen, Inc. Stock Rating

Buy
57
Biogen, Inc. (BIIB) is a Buy

Is Biogen, Inc. overpriced?

  • Biogen, Inc. has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%

Biogen, Inc. Stock Price History

Is BIIB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com

52-Week Data

52-Week High:
185.17
52-Week Low:
110.04

Prediction Charts

Market Cap:
26.5B
Price in USD:
180.75
Volume:
1.8M
Beta:
0.86

Technical Analysis

SMA50:
156.11
SMA100:
145.71
SMA200:
138.01
52-Wk Change:
12.37%

Stock Predictions

  • Is Biogen, Inc. stock public?
    Yes, Biogen, Inc. is a publicly traded company.
  • What is the Biogen, Inc. stock quote today?
    The Biogen, Inc. stock price is 180.75 USD today.
  • How to buy Biogen, Inc. stock online?
    You can buy Biogen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 161.57 164.73 167.87 161.20
Nov-14 164.72 167.55 169.00 163.00
Nov-17 167.00 164.68 167.97 163.50
Nov-18 164.40 168.83 170.78 163.00
Nov-19 168.83 167.93 168.90 165.79
Nov-20 168.15 168.18 170.91 165.75
Nov-21 168.54 175.30 176.02 167.42
Nov-24 177.65 176.82 185.17 175.57
Nov-25 177.07 181.96 182.97 176.09
Nov-26 181.96 181.94 183.93 180.76
Nov-28 182.07 182.09 182.74 180.69
Dec-1 180.15 177.78 181.78 175.88
Dec-2 177.32 180.18 180.55 174.53
Dec-3 180.17 180.75 182.94 178.05

Biogen, Inc. Earnings

Biogen, Inc. Earnings Report: Per Share Biogen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biogen, Inc. Forecast Revenue Growth

Biogen, Inc. Stock Analysis: Historical quarterly revenues per share for Biogen, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.12 per share.

* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.